Teva Pharmaceutical Industries Limited (TEVA)

USD 21.2

(1.53%)

Annual Balance Sheets

(In USD)
Breakdown 2023 2022 2021 2020 2019 2018
Total Assets 43.47 Billion 44 Billion 47.66 Billion 50.64 Billion 57.47 Billion 60.68 Billion
Total Current Assets 12.48 Billion 12.05 Billion 12.57 Billion 13 Billion 13.46 Billion 13.79 Billion
Cash And Short Term Investments 3.22 Billion 2.8 Billion 2.16 Billion 2.17 Billion 1.97 Billion 1.78 Billion
Cash and Cash Equivalents 3.22 Billion 2.8 Billion 2.16 Billion 2.17 Billion 1.97 Billion 1.78 Billion
Short Term Investments - - - - - -
Net Receivables 3.4 Billion 3.69 Billion 4.52 Billion 4.58 Billion 5.67 Billion 5.82 Billion
Inventory 4.02 Billion 3.83 Billion 3.81 Billion 4.4 Billion 4.42 Billion 4.73 Billion
Other Current Assets 505 Million 549 Million 967 Million 710 Million 434 Million 468 Million
Total Non-Current Assets 30.99 Billion 31.95 Billion 35.09 Billion 37.63 Billion 44 Billion 46.88 Billion
Net PPE 6.14 Billion 6.15 Billion 6.47 Billion 6.85 Billion 6.95 Billion 6.86 Billion
Good Will And Intangible Assets 22.56 Billion 23.9 Billion 27.5 Billion 29.54 Billion 36.07 Billion 38.92 Billion
Good Will 17.17 Billion 17.63 Billion 20.04 Billion 20.62 Billion 24.84 Billion 24.91 Billion
Intangible Assets 5.38 Billion 6.27 Billion 7.46 Billion 8.92 Billion 11.23 Billion 14 Billion
Long-Term Investments 8 Million - - - - 58 Million
Tax Assets 1.81 Billion 1.45 Billion 596 Million 695 Million 386 Million 368 Million
Other Non Current Assets 462 Million 441 Million 515 Million 538 Million 591 Million 673 Million
Other Assets 1 Million - -1 Million 1 Million 1 Million -
Total Liabilities 35.35 Billion 35.31 Billion 36.42 Billion 39.57 Billion 42.4 Billion 44.88 Billion
Total Current Liabilities 12.24 Billion 11.46 Billion 11.02 Billion 13.16 Billion 13.67 Billion 14.32 Billion
Account Payables 2.6 Billion 1.88 Billion 1.68 Billion 1.75 Billion 1.71 Billion 1.85 Billion
Tax Payables - - - - - -
Short Term Debt 1.67 Billion 2.1 Billion 1.42 Billion 3.18 Billion 2.34 Billion 2.21 Billion
Deferred Revenue 6.91 Billion 1.45 Billion 7.01 Billion 7.28 Billion 8.72 Billion 9.44 Billion
Other Current Liabilities 1.05 Billion 6.02 Billion 903 Million 931 Million 890 Million 804 Million
Total Non Current Liabilities 23.1 Billion 23.84 Billion 25.39 Billion 26.41 Billion 28.73 Billion 30.56 Billion
Long-Term Debt 18.48 Billion 19.45 Billion 22.03 Billion 23.21 Billion 24.99 Billion 26.7 Billion
Deferred Revenue Non Current - 548 Million - 2.24 Billion - -
Deferred Tax Liabilities Non Current - - - - - -
Other Non Current Liabilities 4.01 Billion 3.29 Billion 2.57 Billion 1 Million 2.64 Billion 1.72 Billion
Other Liabilities - - - - - -
Total Equity 8.12 Billion 8.69 Billion 11.24 Billion 11.06 Billion 15.06 Billion 15.79 Billion
Stock Holders Equity 7.5 Billion 7.89 Billion 10.27 Billion 10.02 Billion 13.97 Billion 14.7 Billion
Common Stock 57 Million 57 Million 57 Million 57 Million 56 Million 56 Million
Retained Earnings -13.53 Billion -12.88 Billion -10.52 Billion -10.94 Billion -6.95 Billion -5.95 Billion
Accumulated other comprehensive income -2.69 Billion -2.83 Billion -2.68 Billion -2.39 Billion -2.31 Billion -2.45 Billion
Common Stock Equity 7.5 Billion 7.89 Billion 10.27 Billion 10.02 Billion 13.97 Billion 14.7 Billion
Capital Lease Obligation 320 Million 349 Million 416 Million 479 Million 435 Million -
Total Investments 8 Million - - - - 58 Million
Total Debt 20.15 Billion 21.56 Billion 23.45 Billion 26.39 Billion 27.34 Billion 28.91 Billion
Net Debt 16.92 Billion 18.76 Billion 21.29 Billion 24.22 Billion 25.36 Billion 27.13 Billion

Balance Sheet Charts